Metabolomics in adult and pediatric nephrology

Molecules

Volumn 18, Issue 5, 2013, Pages 4844-4857

  Fanos, Vassilios ^a,b   Fanni, Claudia ^a   Ottonello, Giovanni ^a   Noto, Antonio ^a   Dessì, Angelica ^a   Mussap, Michele ^c  

^a DEPARTMENT OF RADIOLOGY   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Adult; Children; Kidney; Metabolomics; Nephrology

Indexed keywords

ADOLESCENT; ADULT; CHILD; FEMALE; HUMAN; KIDNEY; KIDNEY DISEASE; MALE; METABOLISM; METABOLOMICS; METHODOLOGY; PRESCHOOL CHILD; REVIEW; URINE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; METABOLOMICS;

EID: 84878280745     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18054844     Document Type: Review

References (58)

1. Carraro, S.; Giordano, G.; Reniero, F.; Perilongo, G.; Baraldi, E. Metabolomics: A New Frontier for Research in Pediatrics. J. Pediatr. 2009, 154, 638-644.
2. Ryan, D.; Robards, K. Metabolomics: The greatest omics of them all? Anal. Chem. 2006, 78, 7954-7958. (Pubitemid 44871759)
3. Goodacre, R. Metabolomics of a superorganism. J. Nutr. 2007, 137, S259-S266.
4. Nicholson, J.K.; Wilson, I.D. Opinion: Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2003, 2, 668-676. (Pubitemid 37361770)
5. Nicholson, J.K.; Holmes, E.; Lindon, J.C.; Wilson, I.D. The challenges of modeling mammalian biocomplexity. Nat. Biotechnol. 2004, 22, 1268-1274. (Pubitemid 39336780)
6. Antonucci, R.; Atzori, L.; Barberini, L.; Fanos, V. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine. Minerva Pediatrica 2010, 62, 145-148.
7. Lindon, J.C.; Nicholson, J.K. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu. Rev. Anal. Chem. 2008, 1, 45-69.
8. Rosewell, R.; Vitols, C. Identifying Metabolite in Biofluids. Available online: http://www.chenomx.com/news/img/page23/ChenomxAppNote.an001.pdf (accessed on 20 March 2013).
9. Atzori, L.; Antonucci, R.; Barberini, L.; Locci, E.; Cesare Marincola, F.; Scano, P.; Cortesi, P.; Agostiniani, R.; Weljie, A.; Lai, A.; et al. V. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front. Biosci. 2010, 2, 725-732.
10. Sung, N.S.; Crowley, W.F.; Genel, M.; Salber, P.; Sandy, L.; Sherwood, L.M.; Johnson, S.B.; Catanese, V.; Tilson, H.; Getz, K.; et al. Central challenges facing the national clinical research enterprise. JAMA 2003, 289, 1278-1287. (Pubitemid 37432909)
11. Hewitt, S.M.; Dear, J.; Star, R.A. Discovery of protein biomarkers for renal diseases. J. Am. Soc. Nephrol. 2004, 15, 1677-1689. (Pubitemid 38822046)
12. Zhao, Y.Y.; Xu, Q. Metabolomics in chronic kidney diseases. Clin. Chim. Acta 2013, pii: S0009-8981(13)00133-2. doi:10.1016/j.cca.2013.03.033.
13. Tomlanovich, S.; Golbetz, H.; Perlroth, M.; Stinson, E.; Myers, B.D. Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am. J. Kidney Dis. 1986, 8. 332-337. (Pubitemid 17235079)
14. Weiss, R.H.; Kim, K. Metabolomics in the study of kidney diseases. Nat. Rev. Nephrol. 2012, 8, 22-33.
15. Fanos, V.; Barberini, L.; Antonucci, R.; Atzori, L. Pharma-metabolomics in neonatology: Is it a dream or a fact? Curr. Pharm. Des. 2012, 18, 2996-3006.
16. Sieber, M.; Hoffmann, D.; Adler, M.; Vaidya, V.S.; Clement, M.; Bonventre, J.V.; Zidek, N.; Rached, E.; Amberg, A.; Callanan, J.J.; et al. Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol. Sci. 2009. 109, 336-349.
17. Boudonck, K.J.; Mitchell, M.W.; Német, L.; Keresztes, L.; Nyska, A.; Shinar, D.; Rosenstock, M. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol. Pathol. 2009. 37, 280-292.
18. Zgoda-Pols, J.R.; Chowdhury, S.; Wirth, M.; Milburn, M.V.; Alexander, D.C.; Alton, K.B. Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: Investigation of nicotinic acid receptor agonists. Toxicol. Appl. Pharmacol. 2011, 255, 48-56.
19. Kikuchi, K.; Itoh, Y.; Tateoka, R.; Ezawa, A.; Murakami, K.; Niwa, T. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry. J. Chromatogr. B 2010, 878, 1662-1668.
20. Dong, F.X.; Huang, D.; He, L.Q. Research on urine metabonomics in chronic kidney disease with kidney-yang deficency. Chin. J. Trad. Chin. Med. Pharmacy 2008, 23, 1109-1113.
21. Di Concetto, G.; Sotte, L.; Pippa, L.; Muccioli, M. Trattato di agopuntura e medicina cinese; UTET: Torino, Italy, 1992.
22. Gronwald, W.; Klein, M.S.; Zeltner, R.; Schulze, B.D.; Reinhold, S.W.; Deutschmann, M.; Immervoll, A.K.; Böger, C.A.; Banas, B.; Eckardt, K.U.; et al. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011, 79, 1244-1253.
23. Nevedomskaya, E.; Pacchiarotta, T.; Artemov, A.; Meissner, A.; van Nieuwkoop, C.; van Dissel, J.T.; Mayboroda, O.A.; Deelder, A.M. 1H NMR-based metabolic profiling of urinary tract infection: Combining multiple statistical models and clinical data. Metabolomics 2012, 8, 1227-1235.
24. Fukui, Y.; Kato, M.; Inoue, Y.; Matsubara, A.; Itoh, K. A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis. J. Chromatogr. B 2009. 877, 3806-3812.
25. Gao, X.; Chen, W.; Li, R.; Wang, M.; Chen, C.; Zeng, R.; Deng, Y. Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum. BMC Syst. Biol. 2012, 6, S14.
26. Bairaktari, E.; Seferiadis, K.; Liamis, G.; Psihogios, N.; Tsolas, O.; Elisaf, M. Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine. Clin. Chem. 2002, 48, 1106-1109. (Pubitemid 34680911)
27. Gartland, K.P.; Bonner, F.W.; Nicholson, J.K. Investigations into the biochemical effects of region-specific nephrotoxins. Mol. Pharmacol. 1989, 39, 242-250. (Pubitemid 19069600)
28. Hauet, T.; Baumert, H.; Gibelin, H.; Hameury, F.; Goujon, J.M.; Carretier, M.; Eugene, M. Non invasive monitoring of citrate, Acetate, Lactate and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Criobiology 2000, 41, 280-291. (Pubitemid 32187989)
29. Suhre, K.; Meisinger, C.; Döring, A.; Altmaier, E.; Belcredi, P.; Gieger, C.; Chang, D.; Milburn, M.V.; Gall, W.E.; Weinberger, K.M.; et al. Metabolomic footprint of diabetes: A multiplatform metabolomics study in an epidemiologic setting. PLoS One 2010, 5, e13953.
30. Van, Q.N.; Klose, J.R.; Lucas, D.A.; Prieto, D.A.; Luke, B.; Collins, J.; Burt, S.K.; Chmurny, G.N.; Issaq, H.J.; Conrads, T.; et al. The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis. Dis. Markers 2004, 19, 169-183. (Pubitemid 38869697)
31. Wikoff, W.R.; Nagle, M.A.; Kouznetsova, V.L.; Tsigelny, I.F.; Nigam, S.K. Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J. Proteome Res. 2011, 10, 2842-2851.
32. Ahn, S.Y.; Jamshidi, N.; Mo, M.L.; Wu, W.; Eraly, S.A.; Dnyanmote, A.; Bush, K.T.; Gallegos, T.F.; Sweet, D.H.; Palsson, B.Ø.; et al. Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis. J. Biol. Chem. 2011, 286, 31522-31531.
33. Eraly, S.A.; Vallon, V.; Vaughn, D.A.; Gangoiti, J.A.; Richter, K.; Nagle, M.; Monte, J.C.; Rieg, T.; Truong, D.M.; Long, J.M.; et al. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J. Biol. Chem. 2006, 281, 5072-5278.
34. Goldman, J.; Becker, M.L.; Jones, B.; Clements, M.; Leeder, S. Development of biomarkers to optimize pediatric patient management: What makes children different? Biomark. Med. 2011, 5, 781-794.
35. Al-Ismaili, Z.; Palijan, A.; Zappitelli, M. Biomarkers of acute kidney injury in children: Discover, evaluation, and clinical application. Pediatr. Nephrol. 2011, 26, 29-40.
36. Hanna, M.H.; Segar, J.L.; Teesch, L.M.; Kasper, D.C.; Schaefer, F.S.; Brophy, P.D. Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats. Pediatr Res. 2013, doi:10.1038/pr.2013.34.
37. Noto, A.; Cibecchini, F.; Fanos V.; Mussap, M. NGAL and Metabolomics: The single biomarker to reveal the metabolism alterations in kidney injury. Biomed. Res. Int. 2013, 2013, 612032:1-612032:6.
38. Beger, R.D.; Holland, R.D.; Sun, J.; Schnackenberg, L.K.; Moore, P.C.; Dent, C.L.; Devarajan, P.; Portilla, D. Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr. Nephrol. 2008. 23, 977-984.
39. Gu, H.; Pan, Z.; Xi, B.; Hainline, B.E.; Shanaiah, N.; Asiago, V.; Gowda, G.A.; Raftery, D. 1H-NMR metabolomics study of age profiling in children. NMR Biomed. 2009, 22, 826-833.
40. Gupta, A.; Bansal, N.; Houston, B. Metabolomics of urinary tract infection: A new uroscope in town. Expert Rev. Mol. Diagn. 2012, 12, 361-369.
41. McCabe, E.R.B. Inborn Errors of Metabolism: The metabolome is our world. Presidential address for the 11th International Congress of Inborn Errors of Metabolism (ICIEM). Mol. Genet. Metab. 2010. 100, 1-5.
42. Nicholson, J.K.; Lindon, J.C. Systems biology: Metabonomics. Nature 2008, 455, 1054-1056.
43. Atzori, L.; Antonucci, R.; Barberini, L.; Griffin, J.L.; Fanos, V. Metabolomics: A new tool for the neonatologist. J. Matern-Fetal Neo. Med. 2009, 22, 50-53.
44. Atzori, L.; Griffin, J.L.; Noto, A.; Fanos, V. Review Metabolomics: A new approach to drug delivery in perinatology. Curr. Med. Chem. 2012, 19, 4654-4661.
45. Fanos, V.; Antonucci, R.; Barberini, L.; Atzori, L. Urinary metabolomics in newborns and infants. Adv. Clin. Chem. 2012, 58, 193-223.
46. Fanos, V.; Antonucci, R.; Barberini, L.; Noto, A.; Atzori, L. Clinical application of metabolomics in neonatology. J. Matern-Fetal Neonatal. Med. 2012, 25, 104-109.
47. Fanos, V.; Barberini, L.; Antonucci, R.; Atzori, L. Metabolomics in neonatology and pediatrics. Clin. Biochem. 2011, 44, 452-454.
48. Fanos, V.; van den Anker, J.; Noto, A.; Mussap, M.; Atzori, L. Metabolomics in neonatology: Fact or fiction? Semin. Fetal Neonatal. Med. 2013, 18, 3-12.
49. Mussap, M.; Noto, A.; Cibecchini, F.; Fanos, V. The importance of biomarkers in neonatology. Semin. Fetal Neonatal. Med. 2013, 18, 56-64.
50. Syggelou, A.; Iacovidou, N.; Atzori, L.; Xanthos, T.; Fanos, V. Metabolomics in the developing human being. Pediatr. Clin. N. Am. 2012, 59, 1039-1058.
51. Christians, U.; Albuisson, J.; Klawitter, J.; Klawitter, J. The Role of Metabolomics in the Study of Kidney Diseases and in the Development of Diagnostic Tools. In Biomarkers of Kidney Disease; Edelstein, C., Ed.; Elsevier: San Diego, CA, USA, 2010; Chapter 3, pp. 39-100.
52. Martin, A.; Fitzpatrick, M.A.; Young, S.P. Metabolomics - a novel window into inflammatory disease. Swiss Med Wkly. 2013, 143, w13743.
53. Drube, J.; Zürbig, P.; Schiffer, E.; Lau, E.; Ure, B.; Glüer, S.; Kirschstein, M.; Pape, L.; Decramer, S.; Bascands, J.L.; et al. Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr. Nephrol. 2010, 25, 1673-1678.
54. Drube, J.; Schiffer, E.; Lau, E.; Petersen, C.; Kirschstein, M.; Kemper, M.J.; Lichtinghagen, R.; Ure, B.; Mischak, H.; Pape, L.; et al. Urinary proteome analysis to exclude severe vesicoureteral reflux. Pediatrics 2012, 129, e356-e363.
55. 1H NMR metabonomics in predicting renal function recoverability after the relief of obstructive uropathy in adult patients. Clin. Biochem. 2013, 46, 346-353.
56. Ng, D.P.; Salim, A.; Liu, Y.; Zou, L.; Xu, F.G.; Huang, S.; Leong, H.; Ong, C.N. A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus. Diabetologia 2012, 55, 499-508.
57. Zhang, A.; Sun, H.; Wu, X.; Wang, X. Urine metabolomics. Clin. Chim. Acta 2012, 24, 65-69.
58. Pesce, F.; Pathan, S.; Schena, F.P. From "omics to personalized medicine in nephrology: Integration is the key. Nephrol. Dial. Transpl. 2013, 28, 24-28.